Pancreatic Cancer Clinical Trials

Find Pancreatic Cancer Clinical Trials Near You

SERum-bank for PANcreatic Cancer

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Biological
Study Type: Observational
SUMMARY

This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case. Today, there is no any effective means of detection... Blood markers can be a simple means of early detection

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.

• At the start of treatment (before surgery / 1st course of chemotherapy)

• Age ≥ 18 years

• Patient affiliated or entitled to a social security system

• Age ≥ 40 years

• Patient affiliated or entitled to a social security system

• Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease

Locations
Other Locations
France
CHU Saint-Etienne
RECRUITING
Saint-etienne
Institut Cancérologique Lucien Newirth (ICLN)
RECRUITING
Saint-priest-en-jarez
Contact Information
Primary
Nicolas WILLIET, MD
nicolas.williet@chu-st-etienne.fr
(0)477829029
Backup
Jean-Marc PHELIP, MD-PhD
j.marc.phelip@chu-st-etienne.fr
( 0)477828320
Time Frame
Start Date: 2020-04-01
Estimated Completion Date: 2026-01-01
Participants
Target number of participants: 400
Treatments
Adenocarcinoma group
Patients with Adenocarcinoma will be included. They will have blood sample at the inclusion visit and at 3 months, 6 months, 9 months and 12 months after.
Control group
Patient with no adenocarcinoma will be included. They will have blood sample at the inclusion visit.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Saint Etienne

This content was sourced from clinicaltrials.gov